Rate My Professor Paul Mitchell

Mitchell's research specializations include retinal vascular disease, age-related eye disease, diabetic eye disease, and macular degeneration. As principal investigator, he has led landmark epidemiological studies such as the Blue Mountains Eye Study and the Sydney Childhood Eye Study, contributing significantly to public health and ophthalmic epidemiology. He has co-authored over 1,145 peer-reviewed papers in major journals including the New England Journal of Medicine and The Lancet, along with more than 75 books, chapters, and letters, garnering over 140,000 citations. His work also covers evidence-based medicine, evaluation of therapies for retinal vein occlusion, diabetic macular edema, and other conditions, health economics for preventing blindness, and participation in pivotal randomized clinical trials as a senior investigator. Career appointments include roles at Westmead Hospital's Department of Ophthalmology since 1989 and the University of Sydney since 2000. Awards include the 2013 Association for Research in Vision and Ophthalmology Achievement Award, 2010 Norman Gregg Medal from the Royal Australian and New Zealand College of Ophthalmologists, 2009 American Academy of Ophthalmology Achievement Award, 2007 RANZCO Medal, and 2004 Association of International Glaucoma Societies award for glaucoma epidemiology research. He has served as ARVO Trustee and Vice President.